NSE: NIFTYPHARMA

22038.70 110.10 (0.50%)

NSE 30 Jun, 2025 3:31 PM (IST)

Nifty Pharma PB	5.4
Nifty Pharma PE	31.6
Nifty Pharma DIV	0.7
Nifty Pharma EPS	697.2

Nifty Pharma News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Ajanta Pharma Ltd. authored by BP Wealth and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BP Wealth

Keep track of all breaking news and updates on Nifty Pharma from all sources in a single place.

Load latest

Is Nifty Pharma worth buying?

316 Votes:

Buy 79.11%

Sell 11.71%

Hold 9.18%